What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Surgery
His main research concerns Internal medicine, Cardiology, Dilated cardiomyopathy, Cardiomyopathy and Heart failure.
His study explores the link between Internal medicine and topics such as Endocrinology that cross with problems in Proinflammatory cytokine and Coronary artery disease.
His study in the field of Idiopathic dilated cardiomyopathy also crosses realms of FLNC.
His studies deal with areas such as Genetics, Hypertrophic cardiomyopathy, Missense mutation and Pathology as well as Cardiomyopathy.
His Heart failure research includes themes of Surgery, Sudden death, Metoprolol, Electrocardiography and Physical exercise.
Gianfranco Sinagra has included themes like Renal function, Stepwise regression, Hazard ratio, Regression analysis and Cohort in his Ejection fraction study.
His most cited work include:
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). (814 citations)
- Truncations of Titin Causing Dilated Cardiomyopathy (783 citations)
- Functional screening identifies miRNAs inducing cardiac regeneration (678 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Heart failure, Ejection fraction and Dilated cardiomyopathy are his primary areas of study.
His work on Cardiomyopathy, Heart transplantation, Idiopathic dilated cardiomyopathy and Myocardial infarction as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
Gianfranco Sinagra studies Cardiomyopathy, namely Right ventricular cardiomyopathy.
His study in Cardiology is interdisciplinary in nature, drawing from both Disease and Hazard ratio.
His research in Heart failure intersects with topics in Sudden death, Metoprolol, Confidence interval, Intensive care medicine and Heart disease.
Gianfranco Sinagra regularly links together related areas like Myocarditis in his Dilated cardiomyopathy studies.
He most often published in these fields:
- Internal medicine (65.98%)
- Cardiology (58.82%)
- Heart failure (34.85%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (65.98%)
- Cardiology (58.82%)
- Heart failure (34.85%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Dilated cardiomyopathy.
His study in the fields of Cardiomyopathy, Sudden cardiac death, Cohort and Myocardial infarction under the domain of Internal medicine overlaps with other disciplines such as In patient.
His studies deal with areas such as Magnetic resonance imaging, Cardiac magnetic resonance and Disease as well as Cardiology.
In his work, Cardiac resynchronization therapy is strongly intertwined with Implantable cardioverter-defibrillator, which is a subfield of Heart failure.
His Ejection fraction research integrates issues from Interquartile range, Myocarditis and Heart transplantation.
His biological study spans a wide range of topics, including Coronary artery disease and Etiology.
Between 2019 and 2021, his most popular works were:
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). (814 citations)
- Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. (265 citations)
- Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Gianfranco Sinagra mainly investigates Internal medicine, Cardiology, Heart failure, Dilated cardiomyopathy and Ejection fraction.
His work often combines Cardiology and In patient studies.
Gianfranco Sinagra has researched Heart failure in several fields, including Interquartile range, Bioinformatics and Confidence interval.
Gianfranco Sinagra has included themes like Phenotype, Coronary artery disease, Cardiomyopathy, Retrospective cohort study and Disease in his Dilated cardiomyopathy study.
His Cardiomyopathy research is multidisciplinary, relying on both Cardiac resynchronization therapy, Left bundle branch block and Early detection.
His Ejection fraction study integrates concerns from other disciplines, such as Myocarditis and Renal function.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
